GlaxoSmithKline PLC (GSK)

37.76
0.09 0.24
NYSE : Health Care
Prev Close 37.67
Open 37.50
Day Low/High 37.48 / 37.74
52 Wk Low/High 37.36 / 45.58
Volume 2.13M
Avg Volume 3.55M
Exchange NYSE
Shares Outstanding 2.44B
Market Cap 91.84B
EPS 5.20
P/E Ratio 21.67
Div & Yield 1.86 (4.90%)

Latest News

Relvar® Ellipta® 100/25 Mcg Gains Approval In Japan For Use In Patients With COPD

Relvar® Ellipta® 100/25 Mcg Gains Approval In Japan For Use In Patients With COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Relvar ® Ellipta ® (fluticasone furoate /...

10 Undervalued High-Yield Dividend Stocks Worth Buying Today

10 Undervalued High-Yield Dividend Stocks Worth Buying Today

Each dividend stock scores well for safety and has a historically high dividend yield.

2 Excellent Dividend-Paying Drug Stocks to Add to Your Portfolio

2 Excellent Dividend-Paying Drug Stocks to Add to Your Portfolio

These two pharmaceutical stocks offer great yields.

GSK Files Regulatory Submission In US For Once-Daily Closed Triple Combination Therapy FF/UMEC/VI For Patients With COPD

GSK Files Regulatory Submission In US For Once-Daily Closed Triple Combination Therapy FF/UMEC/VI For Patients With COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing by GSK of a regulatory submission with the US Food and Drug Administration for the once-daily, closed triple combination...

Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit

Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit

A sale or spinoff of this business will likely get the attention of competitors that want to increase their over-the-counter product units.

Tracing Benjamin Graham's Descendants

Tracing Benjamin Graham's Descendants

Firms' 13F filings show how they've followed in the footsteps of the father of value investing.

Here Are 3 Ways to Play the Growing Market for Vaccines Right Now

Here Are 3 Ways to Play the Growing Market for Vaccines Right Now

This market is exploding in the U.S., presenting better investment opportunities than other types of therapies.

Donald Trump Election Victory Boosts Some Stocks and Sectors

Donald Trump Election Victory Boosts Some Stocks and Sectors

As we all know, the stock market and the economy abhor uncertainty.

SBUX, AAPL, FB: Jim Cramer's Views

SBUX, AAPL, FB: Jim Cramer's Views

Cramer shares his views on the rise of the stay-at-home consumer. Starbucks, Apple and Facebook are among the stocks discussed.

Uncertain Times; Themes That Endure: Jim Cramer's Best Blogs

Uncertain Times; Themes That Endure: Jim Cramer's Best Blogs

Jim Cramer ponders the preciousness of credibility.

Cramer: Don't Just Stand There Like Bambi; Sell Some

Cramer: Don't Just Stand There Like Bambi; Sell Some

Stocks in the health care sector seem to have no underpinnings whatsoever.

Cramer: Credibility Is a Precious Market Commodity

Cramer: Credibility Is a Precious Market Commodity

And if it's lost, good luck getting it back.

European Stocks Mixed on Corporate Earnings, Brexit News

European Stocks Mixed on Corporate Earnings, Brexit News

A partial victory for Brexit opposition and mixed corporate earnings drive markets in Europe.

GlaxoSmithKline Beats Estimates in Strong Third Quarter

GlaxoSmithKline Beats Estimates in Strong Third Quarter

Britain's largest pharmaceuticals company reports growth in its HIV medicines business as it submits a shingles vaccine for FDA approval.

Novartis Beats Third-Quarter Earnings Forecasts on Growth Products, Cost Cuts

Novartis Beats Third-Quarter Earnings Forecasts on Growth Products, Cost Cuts

The group's blood cancer drug Gleevec also holds up better than expected against generic competition.

European Week Ahead: GDP Data, Consumer Poll to Measure Brexit Damage

European Week Ahead: GDP Data, Consumer Poll to Measure Brexit Damage

Forward-looking purchasing managers' indices and earnings from beleaguered lender Deutsche Bank feature among the other release highlights.

What to Watch This Week: Apple Earnings, Third Quarter GDP

What to Watch This Week: Apple Earnings, Third Quarter GDP

For the week of October 24, investors await quarterly results from a slew of major companies, including Apple, along with the first estimate of third quarter GDP.

These 5 Big-Cap Stocks Are Breaking Out After the Debate: Alphabet, Visa and More

These 5 Big-Cap Stocks Are Breaking Out After the Debate: Alphabet, Visa and More

As the dust settles on Wednesday's contentious presidential debate, U.S. markets are actually teetering on the edge of breakout territory.

Shark Tank's O'Leary Bullish on GlaxoSmithKline (GSK)

Shark Tank's O'Leary Bullish on GlaxoSmithKline (GSK)

O'Shares Investment chairman and CNBC Shark Tank investor Kevin O'Leary says GlaxoSmithKline (GSK) has a huge advantage when selling to the U.S. market.

Pound Slump Highlights Brexit Concerns, Lifts FTSE to Near Record

Pound Slump Highlights Brexit Concerns, Lifts FTSE to Near Record

Britain's Brexit fortunes remain difficult to assess as markets offer mixed-signals on EU departure.

GlaxoSmithKline (GSK) Stock Down, McNamara Named CEO of Consumer Healthcare Unit

GlaxoSmithKline (GSK) Stock Down, McNamara Named CEO of Consumer Healthcare Unit

GlaxoSmithKline (GSK) appointed Brian McNamara CEO of its consumer healthcare division on Wednesday.

GlaxoSmithKline Vaccines for Malaria, Zika Make It a Likely Winner

GlaxoSmithKline Vaccines for Malaria, Zika Make It a Likely Winner

This pharmaceutical giant has struggled in recent years but is wisely repositioning itself as the world's largest manufacturer of vaccines.

Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer

Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer

Here is a look at two big pharma stalwarts to determine the better stock to buy for growth and income.

5 Stocks to Sell Now Before It's Too Late

5 Stocks to Sell Now Before It's Too Late

These stocks could be toxic to your portfolio in the month ahead.

European Markets Mixed Ahead of Fed, BOJ Rate Calls on Wednesday

European Markets Mixed Ahead of Fed, BOJ Rate Calls on Wednesday

Oil bounces back, German producer price data point to a continued low inflation outlook.

GlaxoSmithKline (GSK) Stock Lower, Names Walmsley CEO

GlaxoSmithKline (GSK) Stock Lower, Names Walmsley CEO

GlaxoSmithKline (GSK) named Emma Walmsley, the company's head of consumer healthcare, as CEO beginning next March.

5 Things You Must Know Before the Market Opens Tuesday

5 Things You Must Know Before the Market Opens Tuesday

Wells Fargo CEO John Stumpf will apologize Tuesday to the bank's customers in Senate testimony; U.S. stock futures are rising; GlaxoSmithKline names a new CEO.

European Markets Mixed; Pharmaceuticals Group GSK Slips on News of Insider CEO

European Markets Mixed; Pharmaceuticals Group GSK Slips on News of Insider CEO

Oil prices fall, taking shares in the sector down with them, while German producer price data point to a continued low inflation outlook.